✦ LIBER ✦

Cost utility analysis of prophylactic pamidronate for the prevention of skeletal related events in patients with advanced breast cancer

✍ Scribed by G. Dranitsaris; Tom Hsu

Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 73 KB
Volume: 7
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s005200050260

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-utility analysis for advanced breas

Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model

✍ Michael Patrick Lux; M. Hartmann; C. Jackisch; G. Raab; A. Schneeweiß; K. Possin 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 849 KB

The efficacy of acupoint stimulation for

The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review

✍ Li-Fen Chao; Anthony Lin Zhang; Hsueh-Erh Liu; Ming-Huei Cheng; Hung-Bun Lam; Si 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 280 KB

An analysis of a multiple-drug program i

An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine

✍ Dr. David L. Ahmann; Harry F. Bisel; Richard G. Hahn; Robert T. Eagan; John H. E 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 837 KB

An analysis of a multiple-drug program i

An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine

✍ Dr. David L. Ahmann; Harry F. Bisel; Richard G. Hahn; Robert T. Eagan; John H. E 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 837 KB

Epoetin alfa and darbepoetin alfa for th

Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: Comparative analysis of drug utilization, costs, and hematologic response

✍ Ulf Persson; Sixten Borg; Sandra Jansson; Tor Ekman; Lars Franksson; Signe Fries 📂 Article 📅 2005 🏛 Springer Healthcare Communications 🌐 English ⚖ 471 KB

A phase II trial evaluating the palliati

A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

✍ Mark Clemons; George Dranitsaris; Wei Ooi; David E. C. Cole 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 346 KB